Quoin Pharmaceuticals Ltd... (QNRX)
NASDAQ: QNRX
· Real-Time Price · USD
7.50
0.20 (2.67%)
At close: Aug 15, 2025, 3:34 PM
7.48
-0.20%
After-hours: Aug 15, 2025, 04:04 PM EDT
2.67% (1D)
| Bid | 7 |
| Market Cap | 4.41M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -10.44M |
| EPS (ttm) | 958.65 |
| PE Ratio (ttm) | 0.01 |
| Forward PE | -0.27 |
| Analyst | Buy |
| Ask | 7.58 |
| Volume | 4,176 |
| Avg. Volume (20D) | 12,777 |
| Open | 7.38 |
| Previous Close | 7.30 |
| Day's Range | 7.27 - 7.50 |
| 52-Week Range | 5.01 - 54.95 |
| Beta | 1.82 |
About QNRX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol QNRX
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for QNRX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts2 months ago
+0%
QNRX stock has given up its prior gain. Quoin Phar...
Unlock content with
Pro Subscription
2 months ago
+0%
Quoin Pharmaceuticals shares are trading higher after the company announced it received FDA clearance to initiate a second whole-body QRX003 netherton syndrome clinical study.
